Chidem Kurdas
Despite legal and market challenges, pharmaceutical and biotech stocks remain a wellspring of investment strategies. A popular play recently (more…)
Chidem Kurdas
Despite legal and market challenges, pharmaceutical and biotech stocks remain a wellspring of investment strategies. A popular play recently (more…)
Tags:Amylin, Argyle Forum, Carl Icahn, Cerberus Capital, DE Shaw & Co., Grifols SA, Highbridge Capital Management, JP Morgan Chase, Medicis Pharmaceutical Corp., Pfizer, Roche, Seth Rodner
Posted in Equity, Managers, Pharmaceuticals, Regulation | 1 Comment »